EVT 302

· Evotec Neurosciences GmbH

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for EVT 302, covering 2008-06-17 to 2009-05-29. Get the full timeline:

Most recent: Clinical Trial Update: Phase II Study to Evaluate the Effectiveness of EVT 302 in Smoking Cessation. [Phase 2]